Columbia University Research Returned, Reactivated and Approaching 100% Capacity

Columbia University Research Returned, Reactivated and Approaching 100% Capacity

Although a significant number of clinical trials conducted at Columbia University’s Irving Medical Center (CUIMC) were put on hold or delayed during the height of the pandemic in the spring, with the late summer Vagelos College of Physicians and Surgeons and other centers now shift to full throttle ahead with clinical trials and programs. Ranked in or near the top 5 elite medical schools in the United States, since mid-July research teams have reactivated much of what was on hold as scientists have returned to laboratories while clinical sites are back online. With the experience of COVID-19 now ongoing, centers such as CUIMC have a renewed sense of purpose and commitment to not only medical progress but perhaps a research imperative that is ever more connected to the survival of us all.

Columbia Stem Cell Initiative

Recently, Columbia University updated the world that its scientists were back and “re-energized” with the shut downs of March but seeming like a distant memory. Barbara Corneo, PhD, VP&S associate professor in the Department of Rehabilitation & Regenerative Medicine and director of the Stem Cell Core Facility, commented on the center’s website, “We had ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee